Taken together, we link loss of DNA methylation in the JNK2 commuting enhancer with the occurrence of impaired lung function mediated through differential expression of its target gene JNK2, a thus far unknown key player in the development of lung disease. This evidence concerns the gene MAPK9 and lung disorder.